Improved Prognostic Testing for Patients with Triple Negative Breast Cancer

Approximately 40% of patients with stage I-III triple-negative breast cancer (TNBC) have recurrences after standard treatment, whereas the remaining 60% experience long-term disease-free survival. However, there are currently no clinical tests to assess the risk of recurrence in TNBC patients. Continue reading → Improved Prognostic Testing for Patients with Triple Negative Breast Cancer

Defining Pathways for Bone Destruction and Preservation in Cancer

Bone destruction occurs during aging and numerous diseases, such as osteoporosis and cancer. Many cancer patients, including those with breast-to-bone metastasis, have bone osteolysis that is refractory to state-of-the-art treatments. Continue reading → Defining Pathways for Bone Destruction and Preservation in Cancer